BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10402524)

  • 1. The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors.
    Tan IB; Oppelaar H; Ruevekamp MC; Veenhuizen RB; Timmers A; Stewart FA
    Head Neck; 1999 Aug; 21(5):434-41. PubMed ID: 10402524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-cavity Photodynamic Therapy for malignant tumors of the paranasal sinuses: An in vivo light dosimetry study.
    van Doeveren TEM; van Veen RLP; van den Boom F; Tan IB; Schreuder WH; Karakullukçu MB
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101972. PubMed ID: 32835881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies.
    Schweitzer VG
    Lasers Surg Med; 2001; 29(4):305-13. PubMed ID: 11746107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
    Lilge L; Molpus K; Hasan T; Wilson BC
    Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.
    Rigual N; Shafirstein G; Cooper MT; Baumann H; Bellnier DA; Sunar U; Tracy EC; Rohrbach DJ; Wilding G; Tan W; Sullivan M; Merzianu M; Henderson BW
    Clin Cancer Res; 2013 Dec; 19(23):6605-13. PubMed ID: 24088736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia.
    Ikeda H; Tobita T; Ohba S; Uehara M; Asahina I
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):229-35. PubMed ID: 23993848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy.
    Thong PS; Olivo M; Kho KW; Bhuvaneswari R; Chin WW; Ong KW; Soo KC
    J Environ Pathol Toxicol Oncol; 2008; 27(1):35-42. PubMed ID: 18551894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments.
    Nyst HJ; van Veen RL; Tan IB; Peters R; Spaniol S; Robinson DJ; Stewart FA; Levendag PC; Sterenborg HJ
    Lasers Surg Med; 2007 Sep; 39(8):647-53. PubMed ID: 17886277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo fluence rate measurements during Foscan-mediated photodynamic therapy of persistent and recurrent nasopharyngeal carcinomas using a dedicated light applicator.
    van Veen RL; Nyst H; Rai Indrasari S; Adham Yudharto M; Robinson DJ; Tan IB; Meewis C; Peters R; Spaniol S; Stewart FA; Levendag PC; Sterenborg HJ
    J Biomed Opt; 2006; 11(4):041107. PubMed ID: 16965135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical PDT dose dosimetry for pleural Photofrin-mediated photodynamic therapy.
    Sun H; Ong Y; Yang W; Sourvanos D; Dimofte A; Busch TM; Singhal S; Cengel KA; Zhu TC
    J Biomed Opt; 2024 Jan; 29(1):018001. PubMed ID: 38223299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model.
    Dube A; Sharma S; Gupta PK
    Oral Oncol; 2006 Jan; 42(1):77-82. PubMed ID: 16140565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.
    Hopper C; Kübler A; Lewis H; Tan IB; Putnam G
    Int J Cancer; 2004 Aug; 111(1):138-46. PubMed ID: 15185355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin.
    Blant SA; Woodtli A; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
    Photochem Photobiol; 1996 Dec; 64(6):963-8. PubMed ID: 8972639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
    Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
    Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.
    Baas P; Murrer L; Zoetmulder FA; Stewart FA; Ris HB; van Zandwijk N; Peterse JL; Rutgers EJ
    Br J Cancer; 1997; 76(6):819-26. PubMed ID: 9310252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor regression induced by photodynamic treatment with chlorin p(6) in hamster cheek pouch model of oral carcinogenesis: Dependence of mode of tumor cell death on the applied drug dose.
    Dube A; Sharma S; Gupta PK
    Oral Oncol; 2011 Jun; 47(6):467-71. PubMed ID: 21550293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy in head and neck cancer: indications, outcomes, and future prospects.
    Meulemans J; Delaere P; Vander Poorten V
    Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):136-141. PubMed ID: 30724766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indocyanine green-based photodynamic therapy with 785nm light emitting diode for oral squamous cancer cells.
    Lim HJ; Oh CH
    Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):337-42. PubMed ID: 22122922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells.
    Novak B; Heesen L; Schary N; Lübbert H
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():385-392. PubMed ID: 29427796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Photodynamic therapy of the oral mucosa].
    Nauta JM
    Ned Tijdschr Tandheelkd; 1997 Oct; 104(10):377-80. PubMed ID: 11924428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.